|
1
|
Durfee RA, Mohammed M and Luu HH: Review
of osteosarcoma and current management. Rheumatol Ther. 3:221–243.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
International osteosarcoma incidence patterns in children and
adolescents, middle ages and elderly persons. Int J Cancer.
125:229–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma = Pediatric and adolescent osteosarcoma. Springer;
pp. 3–13. 2009
|
|
4
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the Surveillance, Epidemiology, and End Results Program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamplot JD, Denduluri S, Qin J, Li R, Liu
X, Zhang H, Chen X, Wang N, Pratt A, Shui W, et al: The current and
future therapies for human osteosarcoma. Curr Cancer Ther Rev.
9:55–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Carrle D and Bielack SS: Current
strategies of chemotherapy in osteosarcoma. Int Orthop. 30:445–451.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Namløs HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li JP, Liu LH, Li J, Chen Y, Jiang XW,
Ouyang YR, Liu YQ, Zhong H, Li H and Xiao T: Microarray expression
profile of long noncoding RNAs in human osteosarcoma. Biochem
Biophys Res Commun. 433:200–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu H, Zhang Y, Cai XH, Huang JF and Cai L:
Changes in microRNA expression in the MG-63 osteosarcoma cell line
compared with osteoblasts. Oncol Lett. 4:1037–1042. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gai P, Sun H, Wang G, Xu Q, Qi X, Zhang Z
and Jiang L: miR-22 promotes apoptosis of osteosarcoma cells via
inducing cell cycle arrest. Oncol Lett. 13:2354–2358. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li CH, Yu TB, Qiu HW, Zhao X, Zhou CL and
Qi C: miR-150 is downregulated in osteosarcoma and suppresses cell
proliferation, migration and invasion by targeting ROCK1. Oncol
Lett. 13:2191–2197. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yao J, Qin L, Miao S, Wang X and Wu X:
Overexpression of miR-506 suppresses proliferation and promotes
apoptosis of osteosarcoma cells by targeting astrocyte elevated
gene-1. Oncol Lett. 12:1840–1848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang J, Wang D, Xiong J, Chen L and Huang
J: MicroRNA-33a-5p suppresses growth of osteosarcoma cells and is
downregulated in human osteosarcoma. Oncol Lett. 10:2135–2141.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li S, Gao Y, Wang Y, Wang K, Dai ZP, Xu D,
Liu W, Li ZL, Zhang ZD, Yang SH and Yang C: Serum microRNA-17
functions as a prognostic biomarker in osteosarcoma. Oncol Lett.
12:4905–4910. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Novello C, Pazzaglia L, Cingolani C, Conti
A, Quattrini I, Manara MC, Tognon M, Picci P and Benassi MS: miRNA
expression profile in human osteosarcoma: Role of miR-1 and
miR-133b in proliferation and cell cycle control. Int J Oncol.
42:667–675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Fan Q, Li J, Song J and Gu Y:
MiR-124 down-regulation is critical for cancer associated
fibroblasts-enhanced tumor growth of oral carcinoma. Exp Cell Res.
351:100–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hao C, Xu X, Ma J, Xia J, Dai B, Liu L and
Ma Y: MicroRNA-124 regulates the radiosensitivity of non-small cell
lung cancer cells by targeting TXNRD1. Oncol Lett. 13:2071–2078.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao Y, Ling Z, Hao Y, Pang X, Han X,
Califano JA, Shan L and Gu X: MiR-124 acts as a tumor suppressor by
inhibiting the expression of sphingosine kinase 1 and its
downstream signaling in head and neck squamous cell carcinoma.
Oncotarget. 8:25005–25020. 2017.PubMed/NCBI
|
|
22
|
Li SL, Gao HL, Lv XK, Hei YR, Li PZ, Zhang
JX and Lu N: MicroRNA-124 inhibits cell invasion and
epithelial-mesenchymal transition by directly repressing Snail2 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3389–3396.
2017.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Research Council, . Guide for the
Care and Use of Laboratory Animals. National Academy Press;
Washington, DC: 1996
|
|
25
|
Sun AG, Wang MG, Li B and Meng FG:
Down-regulation of miR-124 target protein SCP-1 inhibits
neuroglioma cell migration. Eur Rev Med Pharmacol Sci. 21:723–729.
2017.PubMed/NCBI
|
|
26
|
Li Z, Wang X, Li W, Wu L, Chang L and Chen
H: miRNA-124 modulates lung carcinoma cell migration and invasion.
Int J Clin Pharmacol Ther. 54:603–612. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang F, Wang B, Long H, Yu J, Li F, Hou H
and Yang Q: Decreased miR-124-3p expression prompted breast cancer
cell progression mainly by targeting beclin-1. Clin Lab.
62:1139–1145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang T, Chen M and Sun T: Simvastatin
attenuates TGF-β1-induced epithelial-mesenchymal transition in
human alveolar epithelial cells. Cell Physiol Biochem. 31:863–874.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Villarejo A, Cortés-Cabrera A,
Molina-Ortiz P, Portillo F and Cano A: Differential role of Snail1
and Snail2 zinc fingers in E-cadherin repression and epithelial to
mesenchymal transition. J Biol Chem. 289:930–941. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mathsyaraja H and Ostrowski MC: Setting
Snail2′s pace during EMT. Nat Cell Biol. 14:1122–1123. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang D and Liu S: SOX5 promotes
epithelial-mesenchymal transition in osteosarcoma via regulation of
Snail. J BUON. 22:258–264. 2017.PubMed/NCBI
|
|
32
|
Xiao JN, Yan TH, Yu RM, Gao Y, Zeng WL, Lu
SW, Que HX, Liu ZP and Jiang JH: Long non-coding RNA UCA1 regulates
the expression of Snail2 by miR-203 to promote hepatocellular
carcinoma progression. J Cancer Res Clin Oncol. 143:981–990. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun Z, Hu W, Xu J, Kaufmann AM and Albers
AE: MicroRNA-34a regulates epithelial-mesenchymal transition and
cancer stem cell phenotype of head and neck squamous cell carcinoma
in vitro. Int J Oncol. 47:1339–1350. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cai QQ, Dong YW, Wang R, Qi B, Guo JX, Pan
J, Liu YY, Zhang CY and Wu XZ: MiR-124 inhibits the migration and
invasion of human hepatocellular carcinoma cells by suppressing
integrin αV expression. Sci Rep. 7:407332017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu Z, Zhang Y, Gao N and Wang X:
Overexpression of miR-506 inhibits growth of osteosarcoma through
Snail2. Am J Transl Res. 7:2716–2723. 2015.PubMed/NCBI
|
|
36
|
Diaz-Lopez A, Moreno-Bueno G and Cano A:
Role of microRNA in epithelial to mesenchymal transition and
metastasis and clinical perspectives. Cancer Manag Res. 6:205–216.
2014.PubMed/NCBI
|
